Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, New South Wales, Australia.
Curr Opin Crit Care. 2017 Dec;23(6):491-497. doi: 10.1097/MCC.0000000000000465.
Damage control surgery (DCS) represents a staged surgical approach to the treatment of critically injured trauma patients. Originally described in the context of hepatic trauma and postinjury-induced coagulopathy, the indications for DCS have expanded to the management of extra abdominal trauma and to the management of nontraumatic acute abdominal emergencies. Despite being an accepted treatment algorithm, DCS is based on a limited evidence with current concerns of the variability in practice indications, rates and adverse outcomes in poorly selected patient cohorts.
Recent efforts have attempted to synthesize evidence-based indication to guide clinical practice. Significant progress in trauma-based resuscitation techniques has led to improved outcomes in injured patients and a reduction in the requirement of DCS techniques.
DCS remains an important treatment strategy in the management of specific patient cohorts. Continued developments in early trauma care will likely result in a further decline in the required use of DCS in severely injured patients.
损伤控制性手术(DCS)代表了一种针对严重创伤患者的分阶段手术治疗方法。最初在肝外伤和损伤后诱导的凝血功能障碍的背景下描述,DCS 的适应证已扩展到腹部外伤的处理和非创伤性急性腹部急症的处理。尽管 DCS 是一种被接受的治疗方案,但它的依据是有限的证据,目前人们担心在选择不当的患者群体中,其适应证、应用率和不良结局存在差异。
最近的研究试图综合基于循证的适应证来指导临床实践。创伤复苏技术的显著进步导致受伤患者的结局得到改善,对 DCS 技术的需求减少。
DCS 仍然是特定患者群体治疗的重要策略。早期创伤治疗的持续发展可能会导致严重受伤患者对 DCS 的需求进一步下降。